Answers are grounded in this paper and cite their sources.
Severe acute pancreatitis (SAP) involves systemic inflammation and intestinal barrier dysfunction. This study aimed to assess the efficacy of Qi Huang Tong Mi soft capsules combined with gut probiotics in the treatment of SAP. A total of 120 SAP patients were randomised into four groups: the experimental group (Qi Huang Tong Mi + probiotics + standard care), Qi Huang group, probiotics group, and control group. Treatments lasted 14 days. Inflammatory markers, intestinal barrier indicators, and clinical outcomes were evaluated on days 7 and 14. The experimental group demonstrated the highest efficacy rate (96.67%), with significant reductions in C-reactive protein (CRP), IL-6, IL-8, TNF-α, procalcitonin (PCT), alone with improved gut barrier function. Faster symptom relief, shorter hospital stays, and fewer complications were observed ( P < 0.05). Qi Huang Tong Mi combined with probiotics effectively and safely reduces inflammation, restores intestinal barrier function, and improves clinical outcomes in SAP patients. • QHTMSC plus probiotics improves outcomes in severe acute pancreatitis.Combination therapy with Qi Huang Tong Mi Soft Capsule (QHTMSC) and probiotics significantly improves clinical outcomes in severe acute pancreatitis (SAP). • Reduces inflammation, enhances gut barrier, and restores microbiota. • Leads to faster recovery, shorter stays, fewer complications. • Safe and promising complementary treatment for SAP.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: